|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,231 INR | -0.86% |
|
-0.53% | +44.11% |
| 12/06 | India Equities Close Higher Ahead of US Inflation Data | MT |
| 12/06 | Glenmark Pharmaceuticals Gets US FDA Final Nod for Esomeprazole Magnesium Capsules | MT |
Glenmark Pharmaceuticals Limited provided earnings guidance for the fiscal year 2025. The consolidated revenue target is INR 135,000 million to INR 140,000 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +44.11% | 4.15B | |
| +16.50% | 42.12B | |
| +20.78% | 21.72B | |
| +21.14% | 15.75B | |
| +23.69% | 14.89B | |
| +57.44% | 13.06B | |
| -0.05% | 6.79B | |
| -14.94% | 6.3B | |
| +20.03% | 6.05B | |
| -8.87% | 5.73B |
GLENMARK PHARMACEUTICALS LIMITED 
